These forms are reproduced from opioid agonist Maintenance Treatment: Pharmacists` Guide to Methadone and Buprenorphine in Case of Opioid Use Disorder When dispensing take-home doses, the pharmacist should discuss with the patient the safe use and storage of the drug and document this conversation. Pharmacists are encouraged to have patients sign a written agreement, such as the templates provided here, to ensure that precautions and expectations are clearly understood. Source: Isaac, P., Janecek, E, Kalvik, A. & Zhang, M. (2015). Opioid-agonist maintenance therapy: A Pharmacist`s Guide to Methadone and Buprenorphine for Opioid Use Disorders. Toronto: Centre for Addiction and Mental Health. The pharmacist-patient treatment agreement deals with delivery times and the method of dosage observed. It also helps pharmacists discuss concerns and effects regarding alcohol and other sedative drugs with patients at the beginning of their treatment program and minimize the likelihood of patients presenting intoxicating at the pharmacy. . .